Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

AMD To Rally Around 39%? Here Are 5 Other Price Target Changes For Monday

Author: Lisa Levin | November 14, 2022 08:07am

  • Baird raised Advanced Micro Devices, Inc. (NASDAQ:AMD) price target from $65 to $100. . Baird analyst Tristan Gerra upgraded the stock from Neutral to Outperform. AMD shares rose 5.7% to close at $72.37 on Friday.
  • EF Hutton cut the price target on Fiesta Restaurant Group, Inc. (NASDAQ:FRGI) from $18 to $14.5. EF Hutton analyst Edward Reilly maintained a Buy rating on the stock. Fiesta Restaurant shares fell 4.3% to close at $6.94 on Friday.
  • Goldman Sachs cut Dominion Energy, Inc. (NYSE:D) price target from $72 to $69. Goldman Sachs analyst Michael Lapides upgraded the stock from Sell to Neutral. Dominion Energy shares rose 0.8% to $62.16 in pre-market trading.
  • JP Morgan cut Teva Pharmaceutical Industries Limited (NYSE:TEVA) price target from $11 to $10. JP Morgan analyst Chris Schott downgraded the stock from Neutral to Underweight. Teva Pharmaceutical fell 2.4% to $9.25 in pre-market trading.
  • HC Wainwright & Co. cut Gain Therapeutics, Inc. (NASDAQ:GANX) price target from $12 to $10. B HC Wainwright & Co. analyst Raghuram Selvaraju maintained the stock with a Buy. Gain Therapeutics shares gained 1.3% to close at $3.21 on Friday.
  • Citigroup reduced Agiliti, Inc. (NYSE:AGTI) price target from $24 to $21. Citigroup analyst Jason Cassorla maintained a Buy rating on the stock. Agiliti shares fell 3.2% to close at $15.00 on Friday.

Check out this: Investor Sentiment Increases After S&P 500 Records Best Week Since June

Posted In: AGTI AMD D FRGI GANX TEVA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist